Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H22N2O2S |
| Molecular Weight | 330.444 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CN(C)C)CN1C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C13
InChI
InChIKey=QTQPVLDZQVPLGV-UHFFFAOYSA-N
InChI=1S/C18H22N2O2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)23(21,22)18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3
| Molecular Formula | C18H22N2O2S |
| Molecular Weight | 330.444 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010-12 |
|
| Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells. | 2005-11-10 |
|
| Extractive spectrophotometric methods for the determination of oxomemazine hydrochloride in bulk and pharmaceutical formulations using bromocresol green, bromocresol purple and bromophenol blue. | 2005-04 |
|
| [Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study)]. | 2003-03-04 |
Sample Use Guides
Oxomemazine 0.33 mg/ml syrup.
Suitable for adults and children over 40 kg (from the age of 12 years old).
10 ml 4 times per day.
For children:
The daily dose according to a child’s weight (1ml of syrup per kg per day):
· Child between 13-20 kg (between 2-6 years old): 5ml 2-3 times per day.
· Child between 20-30 kg (between 6-10 years old): 10 ml 2-3 times per day.
· Child between 30-40 kg (between 10-12 years old): 10 ml 3-4 times a day.
Repeat if necessary minimum every 4 hours.
Due to the sedative effect of oxomemazine it is advisable to take this medication in the evening.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:21:10 GMT 2025
by
admin
on
Wed Apr 02 08:21:10 GMT 2025
|
| Record UNII |
305MB38V1C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
R06AD08
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
||
|
WHO-VATC |
QR06AD08
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1412
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
DB13820
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
C73008
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
222-996-8
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
305MB38V1C
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
C119593
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
2025
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
100000083073
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104734
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
Oxomemazine
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
SUB09549MIG
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
156576-01-1
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
SUPERSEDED | |||
|
m8315
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID5023405
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
3689-50-7
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY | |||
|
19396
Created by
admin on Wed Apr 02 08:21:10 GMT 2025 , Edited by admin on Wed Apr 02 08:21:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
